SLS Company Profile and Key Details

Q: Who are the executives of SLS?

Mr. Andrew ElnatanVice President and Head of Regulatory Affairs, Chemistry, Manufacturing and Controls & QualityMr. Jörg W. BreitkopfHead of Clinical OperationsMr. Robert M. FrancomanoSenior Vice President & Chief Commercial OfficerDr. Angelos M. Stergiou M.D., ScD h.c.Founder, Pres, Chief Executive Officer & DirectorMs. Barbara A. WoodExecutive Vice President, Gen. Counsel & Sec.Dr. Dragan Cicic M.D., MBASenior Vice President of Clinical Devel.Mr. John Thomas Burns CPASenior Vice President & Chief Financial OfficerMs. Barbara A. Wood Esq.Executive Vice President, Gen. Counsel & Corporation Sec.

NASDAQ : SLS

SELLAS Life Sciences Group

$12.39

1.86+17.66%

Open: 4:00 PM

55.84

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

SELLAS Life Sciences Group, Inc. (SLS) stock surged +17.66%, trading at $12.39 on NASDAQ, up from the previous close of $10.53. The stock opened at $10.39, fluctuating between $10.32 and $12.43 in the recent session.

Stock Snapshot

10.53

Prev. Close

1.76B

Market Cap

10.3201

Day Low

-50.3

P/E Ratio

-0.2463

EPS (TTM)

-1.24

Cash Flow per Share

10.39

Open

186.03M

Number of Shares

12.43

Day High

99.7%

Free Float in %

-0.25

Book Value

20.75M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jun 26, 2026	10.37	12.43	10.32	12.39	20.75M
Jun 25, 2026	9.21	11.06	8.98	10.53	15.01M
Jun 24, 2026	9.25	9.32	8.81	9.17	4.53M
Jun 23, 2026	8.50	9.25	8.46	9.07	7.21M
Jun 22, 2026	8.37	8.88	8.34	8.53	8.05M
Jun 18, 2026	8.05	8.38	7.91	8.05	14.69M
Jun 17, 2026	7.59	8.12	7.46	7.76	4.65M
Jun 16, 2026	7.60	7.85	7.43	7.53	4.28M
Jun 15, 2026	7.90	8.12	7.53	7.73	5.82M
Jun 12, 2026	7.67	8.13	7.60	7.83	4.06M
Jun 11, 2026	7.20	7.94	7.07	7.75	6.24M
Jun 10, 2026	7.62	7.70	7.11	7.15	6.63M
Jun 09, 2026	8.06	8.09	7.46	7.68	6.84M
Jun 08, 2026	8.51	8.53	7.95	7.98	5.85M
Jun 05, 2026	8.85	9.03	8.13	8.23	6.68M
Jun 04, 2026	8.00	9.22	7.98	9.04	8.3M
Jun 03, 2026	8.12	8.28	7.85	8.19	7.44M
Jun 01, 2026	9.09	9.30	8.78	9.07	7.27M
May 29, 2026	9.20	9.51	8.60	9.31	25.83M
May 28, 2026	8.57	9.24	8.50	9.18	10.15M

Contact Details

New York, NY 10036

United States

https://www.sellaslifesciences.com 646 200 5278

About Company

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009; and Memorial Sloan Kettering Cancer Center for developing and commercializing MSK's WT1 peptide vaccine technology. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.

Stock Peers

ARGX

-1.47-0.17%

argenx SE$887.18 REGN

12.76+2.06%

Regeneron Pharmaceuticals, Inc.$632.90 UTHR

-0.73-0.13%

United Therapeutics Corporation$542.66 MDGL

-1.14-0.22%

Madrigal Pharmaceuticals, Inc.$512.65 VRTX

11.16+2.32%

Vertex Pharmaceuticals Incorporated$491.34 KRYS

12.32+3.42%

Krystal Biotech, Inc.$372.25 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

-0.07-0.02%

Praxis Precision Medicines, Inc.$327.79 LGND

7.67+2.59%

Ligand Pharmaceuticals Incorporated$303.59 ALNY

-1.8-0.61%

Alnylam Pharmaceuticals, Inc.$291.37

Frequently Asked Questions

What is the current SELLAS Life Sciences Group, Inc. (SLS) stock price?

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) stock price is $12.39 in the last trading session. During the trading session, SLS stock reached the peak price of $12.43 while $10.32 was the lowest point it dropped to. The percentage change in SLS stock occurred in the recent session was 17.66% while the dollar amount for the price change in SLS stock was $1.86.

SLS's industry and sector of operation?

The NASDAQ listed SLS is part of Biotechnology industry that operates in the broader Healthcare sector. SELLAS Life Sciences Group, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SLS?

Mr. Andrew Elnatan
Vice President and Head of Regulatory Affairs, Chemistry, Manufacturing and Controls & Quality
Mr. Jörg W. Breitkopf
Head of Clinical Operations
Mr. Robert M. Francomano
Senior Vice President & Chief Commercial Officer
Dr. Angelos M. Stergiou M.D., ScD h.c.
Founder, Pres, Chief Executive Officer & Director
Ms. Barbara A. Wood
Executive Vice President, Gen. Counsel & Sec.
Dr. Dragan Cicic M.D., MBA
Senior Vice President of Clinical Devel.
Mr. John Thomas Burns CPA
Senior Vice President & Chief Financial Officer
Ms. Barbara A. Wood Esq.
Executive Vice President, Gen. Counsel & Corporation Sec.

How SLS did perform over past 52-week?

SLS's closing price is 791.37% higher than its 52-week low of $1.39 where as its distance from 52-week high of $12.43 is -0.32%.

How many employees does SLS have?

Number of SLS employees currently stands at 13.

Link for SLS official website?

Official Website of SLS is: https://www.sellaslifesciences.com

How do I contact SLS?

SLS could be contacted at phone 646 200 5278 and can also be accessed through its website. SLS operates from 7 Times Square, New York, NY 10036, United States.

How many shares of SLS are traded daily?

SLS stock volume for the day was 20.75M shares. The average number of SLS shares traded daily for last 3 months was 7.79M.

What is the market cap of SLS currently?

The market value of SLS currently stands at $1.76B with its latest stock price at $12.39 and 186.03M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	13
Beta	2.51
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	13
Beta	2.51
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

SLS Company Profile and Key Details

SELLAS Life Sciences Group

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Technical Performance

Shareholding & Insider Activity

Dividend & Fair Value

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways